Qualitest Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Qualitest Pharmaceuticals's estimated annual revenue is currently $61.3M per year.(i)
  • Qualitest Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Qualitest Pharmaceuticals has 305 Employees.(i)
  • Qualitest Pharmaceuticals grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.1M858%N/AN/A
#2
$14.3M7182%N/AN/A
#3
$44.8M2237%N/AN/A
#4
$16.7M839%N/AN/A
#5
$25.7M128-4%N/AN/A
#6
$43.2M21528%N/AN/A
#7
$1.3M13117%N/AN/A
#8
$68.3M34013%N/AN/A
#9
$13.7M68-1%N/AN/A
#10
$35.6M177-3%N/AN/A
Add Company

Since 1983, the people of Qualitest have dedicated themselves to researching, manufacturing and delivering affordable, high-quality generic pharmaceuticals. Headquartered in Huntsville, Alabama, the company is now ranked in the industry top ten. With manufacturing facilities in Charlotte, North Carolina and Huntsville, Alabama the company has a portfolio exceeding 700 products.

keywords:N/A

N/A

Total Funding

305

Number of Employees

$61.3M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Qualitest Pharmaceuticals News

2022-04-17 - Global PI Varnish Market 2022 Industry Future Growth, Key ...

... LGM Pharma, Lannett, Beijing 4A Biotech, Novartis Pharma Schweiz, North Star Rx, Par Pharmaceuticals, Qualitest Products, Teva Pharmaceuticals.

2022-04-17 - Pharmaceuticals Packaging Testing Equipment Market ...

Labthink, UNION PARK CAPITAL, WEST PHARMACEUTICAL SERVICES INC., Qualitest International Inc., AMETEK Sensors, Test & Calibration (STC),...

2022-04-17 - Baclofen Market Size, Scope And Outlook | LGM Pharma ...

Baclofen Market Size, Scope And Outlook | LGM Pharma, Lannett, Beijing 4A Biotech, Novartis Pharma Schweiz, North Star Rx, Par Pharmaceuticals, Qualitest...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$57.6M31824%N/A
#2
$57.8M319-4%N/A
#3
$100.2M326-3%N/A
#4
$112.4M33310%N/A
#5
$132.4M3442%N/A